524 related articles for article (PubMed ID: 18221998)
1. Mycophenolate mofetil after methotrexate failure or intolerance in the treatment of scleritis and uveitis.
Sobrin L; Christen W; Foster CS
Ophthalmology; 2008 Aug; 115(8):1416-21, 1421.e1. PubMed ID: 18221998
[TBL] [Abstract][Full Text] [Related]
2. Mycophenolate mofetil therapy for inflammatory eye disease.
Thorne JE; Jabs DA; Qazi FA; Nguyen QD; Kempen JH; Dunn JP
Ophthalmology; 2005 Aug; 112(8):1472-7. PubMed ID: 16061096
[TBL] [Abstract][Full Text] [Related]
3. Mycophenolate mofetil for the treatment of scleritis.
Sen HN; Suhler EB; Al-Khatib SQ; Djalilian AR; Nussenblatt RB; Buggage RR
Ophthalmology; 2003 Sep; 110(9):1750-5. PubMed ID: 13129873
[TBL] [Abstract][Full Text] [Related]
4. Comparison of antimetabolite drugs as corticosteroid-sparing therapy for noninfectious ocular inflammation.
Galor A; Jabs DA; Leder HA; Kedhar SR; Dunn JP; Peters GB; Thorne JE
Ophthalmology; 2008 Oct; 115(10):1826-32. PubMed ID: 18579209
[TBL] [Abstract][Full Text] [Related]
5. Mycophenolate mofetil for ocular inflammation.
Daniel E; Thorne JE; Newcomb CW; Pujari SS; Kaçmaz RO; Levy-Clarke GA; Nussenblatt RB; Rosenbaum JT; Suhler EB; Foster CS; Jabs DA; Kempen JH
Am J Ophthalmol; 2010 Mar; 149(3):423-32.e1-2. PubMed ID: 20042178
[TBL] [Abstract][Full Text] [Related]
6. A randomized clinical trial comparing methotrexate and mycophenolate mofetil for noninfectious uveitis.
Rathinam SR; Babu M; Thundikandy R; Kanakath A; Nardone N; Esterberg E; Lee SM; Enanoria WT; Porco TC; Browne EN; Weinrib R; Acharya NR
Ophthalmology; 2014 Oct; 121(10):1863-70. PubMed ID: 24917273
[TBL] [Abstract][Full Text] [Related]
7. Effect of Corticosteroid-Sparing Treatment With Mycophenolate Mofetil vs Methotrexate on Inflammation in Patients With Uveitis: A Randomized Clinical Trial.
Rathinam SR; Gonzales JA; Thundikandy R; Kanakath A; Murugan SB; Vedhanayaki R; Lim LL; Suhler EB; Al-Dhibi HA; Doan T; Keenan JD; Rao MM; Ebert CD; Nguyen HH; Kim E; Porco TC; Acharya NR;
JAMA; 2019 Sep; 322(10):936-945. PubMed ID: 31503307
[TBL] [Abstract][Full Text] [Related]
8. Visual outcome, treatment results, and prognostic factors in patients with scleritis.
Wieringa WG; Wieringa JE; ten Dam-van Loon NH; Los LI
Ophthalmology; 2013 Feb; 120(2):379-86. PubMed ID: 23177360
[TBL] [Abstract][Full Text] [Related]
9. Comparison Between Methotrexate and Mycophenolate Mofetil Monotherapy for the Control of Noninfectious Ocular Inflammatory Diseases.
Gangaputra SS; Newcomb CW; Joffe MM; Dreger K; Begum H; Artornsombudh P; Pujari SS; Daniel E; Sen HN; Suhler EB; Thorne JE; Bhatt NP; Foster CS; Jabs DA; Nussenblatt RB; Rosenbaum JT; Levy-Clarke GA; Kempen JH;
Am J Ophthalmol; 2019 Dec; 208():68-75. PubMed ID: 31344346
[TBL] [Abstract][Full Text] [Related]
10. Mycophenolate mofetil in the treatment of chronic non-infectious, non-necrotizing scleritis.
Kolomeyer AM; Ragam A; Shah K; Jachens AW; Tu Y; Chu DS
Ocul Immunol Inflamm; 2012 Apr; 20(2):113-8. PubMed ID: 22409564
[TBL] [Abstract][Full Text] [Related]
11. Mycophenolate Mofetil Therapy in Refractory Inflammatory Eye Disease.
Cuchacovich M; Solanes F; Perez C; Verdaguer JI; Verdaguer J; Castiglione E; Carpentier C; Traipe L; Villarroel F
J Ocul Pharmacol Ther; 2016; 32(1):55-61. PubMed ID: 26562247
[TBL] [Abstract][Full Text] [Related]
12. Mycophenolate mofetil as an immunomodulatory agent in the treatment of chronic ocular inflammatory disorders.
Baltatzis S; Tufail F; Yu EN; Vredeveld CM; Foster CS
Ophthalmology; 2003 May; 110(5):1061-5. PubMed ID: 12750115
[TBL] [Abstract][Full Text] [Related]
13. Mycophenolate mofetil for the treatment of uveitis.
Teoh SC; Hogan AC; Dick AD; Lee RW
Am J Ophthalmol; 2008 Nov; 146(5):752-60, 760.e1-3. PubMed ID: 18455143
[TBL] [Abstract][Full Text] [Related]
14. Long-term results of therapy with mycophenolate mofetil in chronic non-infectious uveitis.
Doycheva D; Zierhut M; Blumenstock G; Stuebiger N; Deuter C
Graefes Arch Clin Exp Ophthalmol; 2011 Aug; 249(8):1235-43. PubMed ID: 21720813
[TBL] [Abstract][Full Text] [Related]
15. Mycophenolate mofetil in the treatment of uveitis in children.
Doycheva D; Deuter C; Stuebiger N; Biester S; Zierhut M
Br J Ophthalmol; 2007 Feb; 91(2):180-4. PubMed ID: 16825275
[TBL] [Abstract][Full Text] [Related]
16. Long-term efficacy of mycophenolate mofetil in the control of severe intraocular inflammation.
Lau CH; Comer M; Lightman S
Clin Exp Ophthalmol; 2003 Dec; 31(6):487-91. PubMed ID: 14641155
[TBL] [Abstract][Full Text] [Related]
17. Mycophenolate mofetil therapy for sarcoidosis-associated uveitis.
Bhat P; Cervantes-Castañeda RA; Doctor PP; Anzaar F; Foster CS
Ocul Immunol Inflamm; 2009; 17(3):185-90. PubMed ID: 19585361
[TBL] [Abstract][Full Text] [Related]
18. Methotrexate for ocular inflammatory diseases.
Gangaputra S; Newcomb CW; Liesegang TL; Kaçmaz RO; Jabs DA; Levy-Clarke GA; Nussenblatt RB; Rosenbaum JT; Suhler EB; Thorne JE; Foster CS; Kempen JH;
Ophthalmology; 2009 Nov; 116(11):2188-98.e1. PubMed ID: 19748676
[TBL] [Abstract][Full Text] [Related]
19. Mycophenolate mofetil as an immunosuppressive agent in refractory inflammatory eye disease.
Choudhary A; Harding SP; Bucknall RC; Pearce IA
J Ocul Pharmacol Ther; 2006 Jun; 22(3):168-75. PubMed ID: 16808677
[TBL] [Abstract][Full Text] [Related]
20. Mycophenolate mofetil monotherapy in the management of paediatric uveitis.
Chang PY; Giuliari GP; Shaikh M; Thakuria P; Makhoul D; Foster CS
Eye (Lond); 2011 Apr; 25(4):427-35. PubMed ID: 21423146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
